Tulip Nandu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Long Noncoding Rna

Vascular Endothelial Growth Factor

Top Venues

Molecular cancer research : MCR

Science (New York, N.Y.)

Molecular cancer therapeutics

University of Texas Southwestern Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Southwestern Medical Center Feb 01 2013

United States

Computational Biologist :: OB/GYN

Publications

Dae-Seok Kim, Cristel V Camacho, Rohit Setlem, Kangsan Kim, Srinivas Malladi, Tim Y Hou, Tulip Nandu, Shrikanth S Gadad, W Lee Kraus
Functional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers. Molecular cancer research : MCR 20 (11) (2022)
Rebecca Gupte, Ken Y Lin, Tulip Nandu, Jayanthi S Lea, W Lee Kraus
Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene Expression. Molecular cancer research : MCR 20 (8) (2022)
Lesley B Conrad, Ken Y Lin, Tulip Nandu, Bryan A Gibson, Jayanthi S Lea, W Lee Kraus
ADP-Ribosylation Levels and Patterns Correlate with Gene Expression and Clinical Outcomes in Ovarian Cancers. Molecular cancer therapeutics 19 (1) (2019)
Keun Woo Ryu, Tulip Nandu, Jiyeon Kim, Sridevi Challa, Ralph J DeBerardinis, W Lee Kraus
Metabolic regulation of transcription through compartmentalized NAD+ biosynthesis. Science (New York, N.Y.) 360 (6389) (2018)